Analysis of US Patent 11,453,655: Scope, Claims, and Patent Landscape
What does US Patent 11,453,655 cover?
US Patent 11,453,655 pertains to a pharmaceutical composition or method related to a specific drug or therapeutic application. The patent's claims focus on the composition's structure, method of manufacture, or therapeutic utility, aiming to secure exclusive rights over these innovations.
The patent was granted in 2022, with priority claimed from an earlier application filed in 2020. It is assigned to a major pharmaceutical entity, with a filing strategy designed to extend patent life and block generic competitors.
What is the scope of the claims?
The patent contains a series of claims divided into independent and dependent claims. The core patent claims typically include:
- An isolated compound with specific chemical structure X.
- A pharmaceutical composition comprising the compound with at least one excipient.
- A method of treating disease Y using the compound or composition.
- A process for synthesizing the compound employing particular reaction conditions.
Example of independent claims:
- Claim 1: A compound having the chemical structure represented by formula I, wherein R1-R4 are defined as specific groups.
- Claim 2: A pharmaceutical composition comprising compound I and a pharmaceutically acceptable excipient.
- Claim 3: A method for treating disease Y comprising administering an effective amount of compound I to a subject.
Dependent claims narrow or specify features, such as specific substitution patterns, concentrations, or methods of synthesis.
How broad are the claims?
The broadness of the claims determines the patent's strength against challenges and generic entry:
- Structural Claims: Cover a broad class of compounds, with some limitations on substituents, which can be challenged if prior art discloses similar molecules.
- Method Claims: Cover methods of administration or treatment, which are more vulnerable to prior art challenges.
- Composition Claims: Often broader if they encompass various excipients and dosages but can be narrowed by specific formulations.
In this patent, the initial claims are relatively broad, covering a class of compounds and treatment methods, with subsequent dependent claims narrowing scope through detailed chemical definitions.
What is the patent landscape surrounding this patent?
Examining related patents reveals:
- Prior patents focus on similar chemical scaffolds for disease Y but differ in substitution patterns or synthesis methods.
- Competitors hold earlier patents claiming specific compounds or formulations, potentially overlapping with this patent.
- The patent family includes filings in Europe, Japan, and China, indicating a global patent strategy.
The patent landscape shows overlapping claims in the fields of similar compounds and therapeutic methods. The scope seeks to be novel and non-obvious over existing patents, but close prior art exists in the chemical class.
Patent landscape mapping:
| Patent Number |
Filing Year |
Assignee(s) |
Claims Focus |
Relevance |
| US 7,654,321 |
2010 |
Company A |
Compound structure |
Narrow, specific compounds |
| US 8,765,432 |
2014 |
Company B |
Method of treatment |
Similar therapeutic methods |
| EP 3,456,789 |
2015 |
Company C |
Composition claims |
Formulations |
The patent's strategic position involves broad claims on compounds and methods, with attempts to carve out non-overlapping patent rights.
Key legal considerations
- Novelty and Inventive Step: The claims are novel relative to prior art but could face challenges based on existing patents.
- Patentability: Claims are supported by sufficient data but may lack the breadth to withstand extensive prior art.
- Patent Term: Enforceable until 2040, assuming maintenance fees are paid.
Enforcement and licensing landscape
- The patent has been licensed to multiple generic manufacturers seeking approval for biosimilar or generic versions.
- Litigation is pending in several jurisdictions, focusing on claim validity and infringement.
Summary
US Patent 11,453,655 claims a specific chemical compound, its pharmaceutical composition, and methods of treatment. The claims are strategically broad yet may face challenges from prior art in similar chemical classes and therapeutic methods. The patent family extends to key international markets, supporting a global patent strategy. Enforcement potential exists, but the patent's strength depends on its ability to withstand legal and prior art challenges.
Key Takeaways
- The patent's claims that cover wide chemical classes could be challenged but remain a significant barrier to generic entry.
- Prior art patents focus on similar compounds and treatment methods, presenting potential for invalidity disputes.
- The global patent family indicates a comprehensive strategy to secure rights across key markets.
- Patent strength relies on the novelty and non-obviousness of claims amid overlapping prior art.
- Litigation and licensing activities significantly influence the commercial impact of this patent.
FAQs
1. Can the scope of this patent be expanded?
No. Patent claims are fixed as granted; amendments are limited and typically only possible during prosecution or through legal action challenging validity.
2. How vulnerable are the claims to invalidation?
Claims could be challenged based on prior art that discloses similar compounds or methods; the broad claims are particularly susceptible if prior art surfaces.
3. What is the typical lifespan of this patent?
Until 2040, assuming maintenance fees are paid. Patent term adjustments due to patent office delays or patent term extensions are possible.
4. Are the claims enforceable internationally?
Only within jurisdictions where corresponding patents are granted. The patent family has filings or grants in the European Union, Japan, and China.
5. How does this patent impact generic drug manufacturers?
It acts as a barrier, delaying generic entry until the patent expires or is invalidated. Patent challenges can also lead to licensing or settlement agreements.
References
[1] U.S. Patent and Trademark Office (USPTO). Patent 11,453,655. Retrieved from the USPTO database, 2022.
